Combination therapy versus celecoxib, a single selective COX-2 agent, to reduce gastrointestinal toxicity in arthritic patients: patient and cost-effectiveness considerations

References

• HochbergMCLawrenceRCEverettDFCornoni-HuntleyJEpidemiologic associations of pain in osteoarthritis of the knee: data from the National Health and Nutrition Examination Survey and the National Health and Nutrition Examination-I Epidemiologic Follow-up SurveySemin Arthritis Rheum1989184 Suppl 2492786254
   PubMed Web of Science ®Google Scholar
• TowheedTEMaxwellLJuddMGCattonMHochbergMCWellsGAcetaminophen for osteoarthritisCochrane Database Syst Rev20061CD00425716437479
   PubMed Web of Science ®Google Scholar
• HochbergMCSilmanALSmolenJSWeinblattMEWeismanMHRheumatology4th edEdinburgh, UKMosby Elsevier2007
   Google Scholar
• MooreRADerrySMcQuayHJCyclo-oxygenase-2 selective inhibitors and nonsteroidal antiinflammatory drugs: balancing gastrointestinal and cardiovascular riskBMC Musculoskelet Disord200787317683540
   PubMed Web of Science ®Google Scholar
• BrederCDDewittDKraigRPCharacterization of inducible cyclooxygenase in rat brainJ Comp Neurol19953552963157608344
   PubMed Web of Science ®Google Scholar
• TopperJNCaiJFalbDGimbroneMAIdentification of vascular endothelial genes differentially responsive to fluid mechanical stimuli: Cyclooxygenase-2, manganese superoxide dismutase, and endothelial cell nitric oxide synthase are selectively up-regulated by steady laminar shear stressProc Natl Acad Sci U S A19969310417104228816815
   PubMed Web of Science ®Google Scholar
• FitzGeraldGAPatronoCThe coxibs, selective inhibitors of cyclooxygenase-2N Engl J Med200134543344211496855
   PubMed Web of Science ®Google Scholar
• RobertsLJMorrowJDAnalgesic-antipyretic and antiinflammatory agents and drugs employed in the treatment of goutHardmanJGLimbirdLEGoodman and Gilman’s The Pharmacological Basis of Therapeutics10th edMcGraw-Hill Companies2001
   Google Scholar
• SimonLSWeaverALGrahamDYAntiinflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trialJAMA19992821921192810580457
   PubMed Web of Science ®Google Scholar
• ZhaoSZFiechtnerJITindallEAEvaluation of health-related quality of life of rheumatoid arthritis patients treated with celecoxibArthritis Care Res20001311212114635284
   PubMed Web of Science ®Google Scholar
• GarnerSFidanDFrankishRCelecoxib for rheumatoid arthritisCochrane Database Syst Rev20024CD00383112519610
   PubMedGoogle Scholar
• BensenWGFiechtnerJJMcMillenJITreatment of osteoarthritis with celecoxib, a cyclooxygenase-2 inhibitor: a randomized controlled trialMayo Clin Proc1999741095110510560596
   PubMed Web of Science ®Google Scholar
• KivitzAJMoskowitzRWWoodsEComparative efficacy and safety of celecoxib and naproxen in the treatment of osteoarthritis of the hipJ Int Med Res20012946747911803730
   PubMed Web of Science ®Google Scholar
• GoldsteinJLCorreaPZhaoWWReduced incidence of gastroduodenal ulcers with celecoxib, a novel cyclooxygenase-2 inhibitor, compared to naproxen in patients with arthritisAm J Gastroenterol2001961019102711316141
   PubMed Web of Science ®Google Scholar
• EmeryPZeidlerHKvienTKCelecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparisonLancet19993542106211110609815
   PubMed Web of Science ®Google Scholar
• McKennaFBorensteinDWendtHWallemarkCLefkowithJBGeisGSCelecoxib versus diclofenac in the management of osteoarthritis of the kneeScand J Rheumatol200130111811252686
   PubMed Web of Science ®Google Scholar
• SinghGFortJGGoldsteinJLfor the SUCCESS-I investigatorscelecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I studyAm J Med200611925526616490472
   PubMed Web of Science ®Google Scholar
• LarkaiENSmithJLLidskyMDGastroduodenal mucosa and dyspeptic symptoms in arthritic patients during chronic nonsteroidal antiinflammatory drug useAm J Gastroenterol198782115311583499815
   PubMed Web of Science ®Google Scholar
• LaineLNonsteroidal anti-inflammatory drug gastropathyGastrointest Endosc Clin North Am19966489504
   PubMedGoogle Scholar
• SilversteinFEFaichGGoldsteinJLGastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomized controlled trial. Celecoxib Long-term Arthritis Safety StudyJAMA20002841247125510979111
   PubMed Web of Science ®Google Scholar
• BombardierCLaineLReicinAComparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR study groupN Engl J Med20003431520152811087881
   PubMed Web of Science ®Google Scholar
• SinghGGastrointestinal complications of prescription and over-the-counter nonsteroidal anti-inflammatory drugs: a view from the ARAMIS database. Arthritis, Rheumatism, and Aging Medical Information SystemAm J Ther2000711512111319579
   PubMedGoogle Scholar
• SinghGTriadafilopoulosGEpidemiology of NSAID induced gastrointestinal complicationsJ Rheumatol Suppl199956182410225536
   PubMedGoogle Scholar
• WolfeMMLichtensteinDRSinghGGastrointestinal toxicity of nonsteroidal anti-inflammatory drugsN Engl J Med19993401888189910369853
   PubMed Web of Science ®Google Scholar
• GabrielSEJaakkimainenLBombardierCRisk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysisAnn Intern Med19911157877961834002
   PubMed Web of Science ®Google Scholar
• BellarySVIsaacsPELeeFIUpper gastrointestinal lesions in elderly patients presenting for endoscopy; relevance of NSAID usageAm J Gastroenterol1991869619641858761
   PubMed Web of Science ®Google Scholar
• FriesJFWilliamsCABlochDANonsteroidal anti-inflamatory drug-associated gastropathy: incidence and risk factor modelsAm J Med1991912132221892140
   PubMed Web of Science ®Google Scholar
• LanzaFLChanFKQuigleyEMPractice Parameters Committee of the American College of Gastroenterology. Guidelines for prevention of NSAID-related ulcer complicationsAm J Gastroenterol200910472873819240698
   PubMed Web of Science ®Google Scholar
• ZimmermannKCSarbiaMSchrorKWeberAAConstitutive cyclooxygenase-2 expression in healthy human and rabbit gastric mucosaMol Pharmacol1998545365409730912
   PubMed Web of Science ®Google Scholar
• HuangJQSridharSHuntRHRole of Helicobacter pylori infection and nonsteroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysisLancet2002359142211809181
   PubMed Web of Science ®Google Scholar
• VergaraMCatalanMGisbertJPMeta-analysis: role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID usersAliment Pharmacol Ther2005211411141815948807
   PubMed Web of Science ®Google Scholar
• LeontiadisGISreedharanADorwardSSystematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleedingHealth Technol Assess2007111164
   Web of Science ®Google Scholar
• RostomADubeCWellsGPrevention of NSAID-induced gastroduodenal ulcersCochrane Database Syst Rev20024CD00229610.1002/14651858.CD002296.12519573
   PubMedGoogle Scholar
• BardhanKDAhlbergJHislopWSRapid healing of gastric ulcers with lansoprazoleAliment Pharmacol Ther199482152208038354
   PubMed Web of Science ®Google Scholar
• AgrawalNMCampbellDRSafdiMASuperiority of lansoprazole vs ranitidine in healing nonsteroidal anti-inflammatory drug-associated gastric ulcers: results of a double-blind, randomized, multicenter study – NSAID-Associated Gastric Ulcer Study GroupArch Intern Med20001601455146110826458
   PubMed Web of Science ®Google Scholar
• YeomansNDTulassayZJuhaszLA comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs: acid Suppression Trial: ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study GroupN Engl J Med19983387197269494148
   PubMed Web of Science ®Google Scholar
• GoldsteinJLJohansonJFHawkeyCJClinical trial: healing of NSAID-associated gastric ulcers in patients continuing NSAID therapy: a randomized study comparing ranitidine with esomeprazoleAliment Pharmacol Ther2007261101111117894652
   PubMed Web of Science ®Google Scholar
• GoldsteinJLJohansonJFSuchowerLJHealing of gastric ulcers with esomeprazole versus ranitidine in patients who continued to receive NSAID therapy: a randomized trialAm J Gastroenterol20051002650265716393215
   PubMed Web of Science ®Google Scholar
• AroraGSinghGTriadafilopoulosGProton pump inhibitors for gastroduodenal damage related to nonsteroidal anti-inflammatory drugs or aspirin: twelve important questions for clinical practiceClin Gastroenterol Hepatol2009772573519306941
   PubMed Web of Science ®Google Scholar
• YeomansNDSvedbergLENaesdalJIs ranitidine therapy sufficient for healing peptic ulcers associated with non-steroidal anti-inflammatory drug use?Int J Clin Pract2006601401140717073837
   PubMed Web of Science ®Google Scholar
• WeinblattMEGenoveseMCKivitzAJEfficacy, safety and tolerability of HZT-501, including users of low-dose aspirin, a single-tablet combination of ibuprofen-famotidine: results of two Phase 3 trialsArthritis Rheum201062Suppl 1094510.1002/art.28713
   Google Scholar
• SilversteinFEGrahamDYSeniorJRMisoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trialAnn Intern Med19951232412497611589
   PubMed Web of Science ®Google Scholar
• RaskinJBWhiteRHJacksonJEMisoprostol dosage in the prevention of nonsteroidal anti-inflammatory drug-induced gastric and duodenal ulcers: a comparison of three regimensAnn Intern Med19951233443507625622
   PubMed Web of Science ®Google Scholar
• KochMDeziAFerrarioFCapursoIPrevention of nonsteroidal anti-inflammatory drug-induced gastrointestinal mucosal injury. A meta-analysis of randomized controlled clinical trialsArch Intern Med1996156232123328911239
   PubMedGoogle Scholar
• GrahamDYAgrawalNMCampbellDRUlcer prevention in long-term users of nonsteroidal anti-inflammatory drugs: results of a double-blind, randomized, multicenter, active. and placebo-controlled study of misoprostol vs lansoprazoleArch Intern Med2002162160175
   Google Scholar
• HooperLBrownTJElliottRPayneKRobertsCSymmonsDThe effectiveness of five strategies for the prevention of gastrointestinal toxicity induced by non-steroidal anti-inflammatory drugs: systematic reviewBMJ200432994815475342
   PubMed Web of Science ®Google Scholar
• OkieSMissing data on Celebrex. Full study altered picture of drugWashington Post20015A11
   Google Scholar
• WrightJMPerryTLBassettKLChambersGKReporting of 6-month vs 12-month data in a clinical trial of celecoxibJAMA200128623982400
   PubMed Web of Science ®Google Scholar
• HrachovecJBMoraMReporting of 6-month vs 12-month data in a clinical trial of celecoxibJAMA20012862398
   PubMed Web of Science ®Google Scholar
• JüniPRutjesAWDieppePAAre selective COX 2 inhibitors superior to traditional non steroidal anti-inflammatory drugs?BMJ20023241287128812039807
   PubMed Web of Science ®Google Scholar
• ChanFKHungLCSuenBYCelecoxib versus diclofenac and omeprazole in reducing the risk of recurrent ulcer bleeding in patients with arthritisN Engl J Med20023472104211012501222
   PubMed Web of Science ®Google Scholar
• LaiKCChuKMHuiWMCelecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complicationsAm J Med20051181271127816271912
   PubMed Web of Science ®Google Scholar
• ChanFKLanasAScheimanJBergerMFNguyenHGoldsteinJLCelecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomised trialLancet201037617317920638563
   PubMed Web of Science ®Google Scholar
• ScheimanJMYeomansNDTalleyNJPrevention of ulcers by esomeprazole in at-risk patients using non-selective NSAIDs and COX-2 inhibitorsAm J Gastroenterol200610170171016494585
   PubMed Web of Science ®Google Scholar
• ChanFKWongVWSuenBYCombination of a cyclooxygenase-2 inhibitor and a proton-pump inhibitor for prevention of recurrent ulcer bleeding in patients at very high risk: a double-blind, randomised trialLancet20073691621162617499604
   PubMed Web of Science ®Google Scholar
• TargownikLEMetgeCJLeungSChateauDGThe relative efficacies of gastroprotective strategies in chronic users of nonsteroidal anti-inflammatory drugsGastroenterology200813493794418294634
   PubMed Web of Science ®Google Scholar
• BrownTJHooperLElliottRAA comparison of the cost-effectiveness of five strategies for the prevention of non-steroidal anti-inflammatory drug-induced gastrointestinal toxicity: a systematic review with economic modelingHealth Technol Assess2006101183
   Web of Science ®Google Scholar
• LatimerNLordJGrantRLO’MahonyRDicksonJConaghanPGNational Institute for Health and Clinical Excellence Osteoarthritis Guideline Development GroupCost effectiveness of COX 2 selective inhibitors and traditional NSAIDs alone or in combination with a proton pump inhibitor for people with osteoarthritisBMJ2009339b253819602530
   PubMed Web of Science ®Google Scholar
• LaineLCurtisSPCryerBKaurACannonCAssessment of upper gastrointestinal safety of etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparisonLancet200736946547317292766
   PubMed Web of Science ®Google Scholar
• FarkouhMEKirschnerHComparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trialLancet200436467568415325832
   PubMed Web of Science ®Google Scholar
• SchnitzerTJBurmesterGRMyslerEComparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), reduction in ulcer complications: randomised controlled trialLancet200436466567415325831
   PubMed Web of Science ®Google Scholar